PubMed:22820256
Annnotations
PubMed_ArguminSci
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 78-151 | DRI_Background | denotes | Medulloblastomas are the most common malignant brain tumours in children. |
| T2 | 152-326 | DRI_Challenge | denotes | Identifying and understanding the genetic events that drive these tumours is critical for the development of more effective diagnostic, prognostic and therapeutic strategies. |
| T3 | 327-472 | DRI_Background | denotes | Recently, our group and others described distinct molecular subtypes of medulloblastoma on the basis of transcriptional and copy number profiles. |
| T4 | 473-631 | DRI_Approach | denotes | Here we use whole-exome hybrid capture and deep sequencing to identify somatic mutations across the coding regions of 92 primary medulloblastoma/normal pairs. |
| T5 | 632-780 | DRI_Outcome | denotes | Overall, medulloblastomas have low mutation rates consistent with other paediatric tumours, with a median of 0.35 non-silent mutations per megabase. |
| T6 | 781-964 | DRI_Approach | denotes | We identified twelve genes mutated at statistically significant frequencies, including previously known mutated genes in medulloblastoma such as CTNNB1, PTCH1, MLL2, SMARCA4 and TP53. |
| T7 | 965-1161 | DRI_Background | denotes | Recurrent somatic mutations were newly identified in an RNA helicase gene, DDX3X, often concurrent with CTNNB1 mutations, and in the nuclear co-repressor (N-CoR) complex genes GPS2, BCOR and LDB1. |
| T8 | 1162-1319 | DRI_Outcome | denotes | We show that mutant DDX3X potentiates transactivation of a TCF promoter and enhances cell viability in combination with mutant, but not wild-type, β-catenin. |
| T9 | 1320-1606 | DRI_Outcome | denotes | Together, our study reveals the alteration of WNT, hedgehog, histone methyltransferase and now N-CoR pathways across medulloblastomas and within specific subtypes of this disease, and nominates the RNA helicase DDX3X as a component of pathogenic β-catenin signalling in medulloblastoma. |
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 926-932 | gene:1499 | denotes | CTNNB1 |
| T1 | 902-917 | disease:C0025149 | denotes | medulloblastoma |
| R1 | T0 | T1 | associated_with | CTNNB1,medulloblastoma |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 78-94 | HP_0002885 | denotes | Medulloblastomas |
| T2 | 131-138 | HP_0002664 | denotes | tumours |
| T3 | 218-225 | HP_0002664 | denotes | tumours |
| T4 | 399-414 | HP_0002885 | denotes | medulloblastoma |
| T5 | 544-561 | HP_0001428 | denotes | somatic mutations |
| T6 | 602-617 | HP_0002885 | denotes | medulloblastoma |
| T7 | 641-657 | HP_0002885 | denotes | medulloblastomas |
| T8 | 715-722 | HP_0002664 | denotes | tumours |
| T9 | 902-917 | HP_0002885 | denotes | medulloblastoma |
| T10 | 975-992 | HP_0001428 | denotes | somatic mutations |
| T11 | 1437-1453 | HP_0002885 | denotes | medulloblastomas |
| T12 | 1590-1605 | HP_0002885 | denotes | medulloblastoma |
Allie
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| SS1_22820256_7_0 | 1098-1118 | expanded | denotes | nuclear co-repressor |
| SS2_22820256_7_0 | 1120-1125 | abbr | denotes | N-CoR |
| AE1_22820256_7_0 | SS1_22820256_7_0 | SS2_22820256_7_0 | abbreviatedTo | nuclear co-repressor,N-CoR |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 22820256-6#145#151#gene1499 | 926-932 | gene1499 | denotes | CTNNB1 |
| 22820256-6#121#136#diseaseC0025149 | 902-917 | diseaseC0025149 | denotes | medulloblastoma |
| 22820256-9#198#210#gene55308 | 1518-1530 | gene55308 | denotes | RNA helicase |
| 22820256-9#198#210#gene9879 | 1518-1530 | gene9879 | denotes | RNA helicase |
| 22820256-9#198#210#gene8449 | 1518-1530 | gene8449 | denotes | RNA helicase |
| 22820256-9#211#216#gene1654 | 1531-1536 | gene1654 | denotes | DDX3X |
| 22820256-9#270#285#diseaseC0025149 | 1590-1605 | diseaseC0025149 | denotes | medulloblastoma |
| 145#151#gene1499121#136#diseaseC0025149 | 22820256-6#145#151#gene1499 | 22820256-6#121#136#diseaseC0025149 | associated_with | CTNNB1,medulloblastoma |
| 198#210#gene55308270#285#diseaseC0025149 | 22820256-9#198#210#gene55308 | 22820256-9#270#285#diseaseC0025149 | associated_with | RNA helicase,medulloblastoma |
| 198#210#gene9879270#285#diseaseC0025149 | 22820256-9#198#210#gene9879 | 22820256-9#270#285#diseaseC0025149 | associated_with | RNA helicase,medulloblastoma |
| 198#210#gene8449270#285#diseaseC0025149 | 22820256-9#198#210#gene8449 | 22820256-9#270#285#diseaseC0025149 | associated_with | RNA helicase,medulloblastoma |
| 211#216#gene1654270#285#diseaseC0025149 | 22820256-9#211#216#gene1654 | 22820256-9#270#285#diseaseC0025149 | associated_with | DDX3X,medulloblastoma |
DisGeNet-2017-sample
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2650 | 1518-1530 | gene:55308 | denotes | RNA helicase |
| T2651 | 1590-1605 | disease:C0025149 | denotes | medulloblastoma |
| R1 | T2650 | T2651 | associated_with | RNA helicase,medulloblastoma |
| R2 | T2650 | T2651 | associated_with | RNA helicase,medulloblastoma |
| R3 | T2650 | T2651 | associated_with | RNA helicase,medulloblastoma |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-77 | Sentence | denotes | Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. |
| TextSentencer_T2 | 78-151 | Sentence | denotes | Medulloblastomas are the most common malignant brain tumours in children. |
| TextSentencer_T3 | 152-326 | Sentence | denotes | Identifying and understanding the genetic events that drive these tumours is critical for the development of more effective diagnostic, prognostic and therapeutic strategies. |
| TextSentencer_T4 | 327-472 | Sentence | denotes | Recently, our group and others described distinct molecular subtypes of medulloblastoma on the basis of transcriptional and copy number profiles. |
| TextSentencer_T5 | 473-631 | Sentence | denotes | Here we use whole-exome hybrid capture and deep sequencing to identify somatic mutations across the coding regions of 92 primary medulloblastoma/normal pairs. |
| TextSentencer_T6 | 632-780 | Sentence | denotes | Overall, medulloblastomas have low mutation rates consistent with other paediatric tumours, with a median of 0.35 non-silent mutations per megabase. |
| TextSentencer_T7 | 781-964 | Sentence | denotes | We identified twelve genes mutated at statistically significant frequencies, including previously known mutated genes in medulloblastoma such as CTNNB1, PTCH1, MLL2, SMARCA4 and TP53. |
| TextSentencer_T8 | 965-1161 | Sentence | denotes | Recurrent somatic mutations were newly identified in an RNA helicase gene, DDX3X, often concurrent with CTNNB1 mutations, and in the nuclear co-repressor (N-CoR) complex genes GPS2, BCOR and LDB1. |
| TextSentencer_T9 | 1162-1319 | Sentence | denotes | We show that mutant DDX3X potentiates transactivation of a TCF promoter and enhances cell viability in combination with mutant, but not wild-type, β-catenin. |
| TextSentencer_T10 | 1320-1606 | Sentence | denotes | Together, our study reveals the alteration of WNT, hedgehog, histone methyltransferase and now N-CoR pathways across medulloblastomas and within specific subtypes of this disease, and nominates the RNA helicase DDX3X as a component of pathogenic β-catenin signalling in medulloblastoma. |
| T1 | 0-77 | Sentence | denotes | Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. |
| T2 | 78-151 | Sentence | denotes | Medulloblastomas are the most common malignant brain tumours in children. |
| T3 | 152-326 | Sentence | denotes | Identifying and understanding the genetic events that drive these tumours is critical for the development of more effective diagnostic, prognostic and therapeutic strategies. |
| T4 | 327-472 | Sentence | denotes | Recently, our group and others described distinct molecular subtypes of medulloblastoma on the basis of transcriptional and copy number profiles. |
| T5 | 473-631 | Sentence | denotes | Here we use whole-exome hybrid capture and deep sequencing to identify somatic mutations across the coding regions of 92 primary medulloblastoma/normal pairs. |
| T6 | 632-780 | Sentence | denotes | Overall, medulloblastomas have low mutation rates consistent with other paediatric tumours, with a median of 0.35 non-silent mutations per megabase. |
| T7 | 781-964 | Sentence | denotes | We identified twelve genes mutated at statistically significant frequencies, including previously known mutated genes in medulloblastoma such as CTNNB1, PTCH1, MLL2, SMARCA4 and TP53. |
| T8 | 965-1161 | Sentence | denotes | Recurrent somatic mutations were newly identified in an RNA helicase gene, DDX3X, often concurrent with CTNNB1 mutations, and in the nuclear co-repressor (N-CoR) complex genes GPS2, BCOR and LDB1. |
| T9 | 1162-1319 | Sentence | denotes | We show that mutant DDX3X potentiates transactivation of a TCF promoter and enhances cell viability in combination with mutant, but not wild-type, β-catenin. |
| T10 | 1320-1606 | Sentence | denotes | Together, our study reveals the alteration of WNT, hedgehog, histone methyltransferase and now N-CoR pathways across medulloblastomas and within specific subtypes of this disease, and nominates the RNA helicase DDX3X as a component of pathogenic β-catenin signalling in medulloblastoma. |
UBERON-AE
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 125-130 | http://purl.obolibrary.org/obo/UBERON_0000955 | denotes | brain |
performance-test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 125-130 | http://purl.obolibrary.org/obo/UBERON_0000955 | denotes | brain |